As of March 31, 2026, CXI Healthcare Technology Group Limited carries a market capitalization of 65.91B, placing it among publicly traded companies globally. Its enterprise value stands at 19.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 65.91B |
| Enterprise Value | 19.66B |
As of March 31, 2026, CXI Healthcare Technology Group Limited has 7.47M shares outstanding.
| Shares Outstanding | 7.47M |
These figures are as of March 31, 2026.
| PB Ratio | 0.11 |
| P/TBV Ratio | 0.11 |
As of March 31, 2026, CXI Healthcare Technology Group Limited maintains a current ratio of 57.68, meaning it holds 57.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 57.68 |
| Quick Ratio | 49.22 |
| Debt / Equity | 0.15 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 26.00 |
As of the close on November 17, 2026, CXI Healthcare Technology Group Limited's stock has declined approximately 78.95% over the past 52 weeks. The 50-day moving average sits at 3,857.30, while the 200-day moving average is 9,677.10.
| 52-Week Price Change | -78.95% |
| 50-Day Moving Average | 3,857.30 |
| 200-Day Moving Average | 9,677.10 |
As of March 31, 2026, CXI Healthcare Technology Group Limited holds 47.08B in cash and equivalents against 832.28M in total debt, resulting in a net debt position of -46.46B. Total book value stands at 573.55B, with working capital of 54.22B providing operational flexibility.
| Cash & Cash Equivalents | 47.08B |
| Total Debt | 832.28M |
| Net Debt | -46.46B |
| Equity (Book Value) | 573.55B |
| Book Value Per Share | 76,791.89 |
| Working Capital | 54.22B |
These figures cover the twelve months ended March 31, 2026.
| Capital Expenditures | -95.59B |
CXI Healthcare Technology Group Limited's most recent stock split took place on October 6, 2026 with a 5:1 split ratio.
| Last Split Date | 10/6/2026 |
| Split Ratio | 5:1 |
Already premium?